Stevens Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-774
| Closed | -$251K | – | 285 |
|
|
2019
Q4 | $251K | Buy |
+774
| New | +$251K | 0.02% | 482 |
|
|
2018
Q4 | – | Sell |
-4,037
| Closed | -$3.69M | – | 837 |
|
|
2018
Q3 | $3.69M | Buy |
4,037
+2,794
| +225% | +$2.56M | 0.14% | 200 |
|
|
2018
Q2 | $910K | Sell |
1,243
-14
| -1% | -$10.2K | 0.03% | 447 |
|
|
2018
Q1 | $2M | Buy |
+1,257
| New | +$2M | 0.08% | 288 |
|
|
2017
Q3 | – | Sell |
-916
| Closed | -$269K | – | 1001 |
|
|
2017
Q2 | $269K | Buy |
+916
| New | +$269K | 0.01% | 704 |
|
|
2017
Q1 | – | Sell |
-1,274
| Closed | -$234K | – | 1024 |
|
|
2016
Q4 | $234K | Buy |
+1,274
| New | +$234K | 0.01% | 743 |
|
|
2015
Q3 | – | Sell |
-2,073
| Closed | -$389K | – | 1137 |
|
|
2015
Q2 | $389K | Buy |
+2,073
| New | +$389K | 0.01% | 684 |
|
|
2015
Q1 | – | Sell |
-1,410
| Closed | -$328K | – | 1143 |
|
|
2014
Q4 | $328K | Buy |
1,410
+444
| +46% | +$103K | 0.01% | 689 |
|
|
2014
Q3 | $175K | Buy |
966
+285
| +42% | +$51.6K | 0.01% | 881 |
|
|
2014
Q2 | $131K | Sell |
681
-545
| -44% | -$105K | ﹤0.01% | 984 |
|
|
2014
Q1 | $223K | Sell |
1,226
-286
| -19% | -$52K | 0.01% | 895 |
|
|
2013
Q4 | $257K | Buy |
+1,512
| New | +$257K | 0.01% | 835 |
|